Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Raabe

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Physical Review Letters|April 6, 2019
Coherent Excitation of Heterosymmetric Spin Waves with Ultrashort WavelengthsG Dieterle, J Förster, H Stoll, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferonJ P Zarski, M Maynard-Muet, S Chousterman, et al.
Nature Communications|March 8, 2018
Current-driven dynamics and inhibition of the skyrmion Hall effect of ferrimagnetic skyrmions in GdFeCo filmsSeonghoon Woo, Kyung Mee Song, Xichao Zhang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 7, 2000
Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis: controlled randomized trial in 203 patientsE Boucher, D Guyader, S Jacquelinet, et al.
Cancer Discovery|February 7, 2025
LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal AdenocarcinomaEunae You, Bidish K Patel, Alexandra S Rojas, et al.
Schizophrenia (Heidelberg, Germany)|December 20, 2024
Investigation of choroid plexus variability in schizophrenia-spectrum disorders-insights from a multimodal studyVladislav Yakimov, Joanna Moussiopoulou, Lukas Roell, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 9, 2025
Clinical deep phenotyping of treatment response in schizophrenia (CDP-STAR): design and methodology of a prospective multimodal observational studyVladislav Yakimov, Lara Neuwinger, Madeleine M Weber, et al.
Schizophrenia (Heidelberg, Germany)|January 23, 2026
The link between GABA levels and P300 abnormalities in schizophrenia spectrum disorders: regional and symptom-based insightsBerkhan Karslı, Verena Meisinger, Genc Hasanaj, et al.
Scandinavian Journal of Gastroenterology|July 27, 2000
Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferonR E Poupon, A M Bonnand, P E Queneau, et al.
The European Journal of Neuroscience|October 4, 2025
Periodic and Aperiodic Alterations of Resting-State EEG in Schizophrenia Spectrum Disorders: Cognitive and Clinical InsightsGenc Hasanaj, Iris Jaeger, Berkhan Karsli, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Physical Review Letters|April 6, 2019
Coherent Excitation of Heterosymmetric Spin Waves with Ultrashort WavelengthsG Dieterle, J Förster, H Stoll, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferonJ P Zarski, M Maynard-Muet, S Chousterman, et al.
Nature Communications|March 8, 2018
Current-driven dynamics and inhibition of the skyrmion Hall effect of ferrimagnetic skyrmions in GdFeCo filmsSeonghoon Woo, Kyung Mee Song, Xichao Zhang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 7, 2000
Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis: controlled randomized trial in 203 patientsE Boucher, D Guyader, S Jacquelinet, et al.
Cancer Discovery|February 7, 2025
LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal AdenocarcinomaEunae You, Bidish K Patel, Alexandra S Rojas, et al.
Schizophrenia (Heidelberg, Germany)|December 20, 2024
Investigation of choroid plexus variability in schizophrenia-spectrum disorders-insights from a multimodal studyVladislav Yakimov, Joanna Moussiopoulou, Lukas Roell, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 9, 2025
Clinical deep phenotyping of treatment response in schizophrenia (CDP-STAR): design and methodology of a prospective multimodal observational studyVladislav Yakimov, Lara Neuwinger, Madeleine M Weber, et al.
Schizophrenia (Heidelberg, Germany)|January 23, 2026
The link between GABA levels and P300 abnormalities in schizophrenia spectrum disorders: regional and symptom-based insightsBerkhan Karslı, Verena Meisinger, Genc Hasanaj, et al.
Scandinavian Journal of Gastroenterology|July 27, 2000
Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferonR E Poupon, A M Bonnand, P E Queneau, et al.
The European Journal of Neuroscience|October 4, 2025
Periodic and Aperiodic Alterations of Resting-State EEG in Schizophrenia Spectrum Disorders: Cognitive and Clinical InsightsGenc Hasanaj, Iris Jaeger, Berkhan Karsli, et al.
Pageof 10